Literature DB >> 17923856

PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy.

M Gacci1, S Serni, A Lapini, G Vittori, G Vignolini, G Nesi, M Carini.   

Abstract

A 64-year-old man was treated with brachytherapy for prostate cancer. Prostate-specific antigen (PSA) nadir was achieved at 3 months, while at 24 months PSA increased to 18.7 ng ml(-1). Re-biopsy and imaging revealed locally recurrent prostate carcinoma without metastasis. The patient was treated with salvage radical prostatectomy, and the surgical specimen underwent double-blind evaluation with RX scan and whole-mount histopathology sections. Radiology revealed an area without any seeds in the right base of the prostate, and pathologic assessment demonstrated adenocarcinoma involving the right base of the gland. This case is indicative of tumor relapse occurring for seed migration after good initial positioning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923856     DOI: 10.1038/sj.pcan.4501011

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  1 in total

1.  Seed loss in prostate brachytherapy : Operator dependency and impact on dosimetry.

Authors:  Nancy El-Bared; Natanel Sebbag; Dominic Béliveau-Nadeau; Yannick Hervieux; Renée Larouche; Daniel Taussky; Guila Delouya
Journal:  Strahlenther Onkol       Date:  2016-02-29       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.